Last Funding Type: Venture - Series Unknown
Headquarters: Abingdon, Oxfordshire, United Kingdom
Investor Type: Company
Investment Stage: N/A
Total Funding: $102.5M
Employee Number: 51-100
Funding Status: N/A
Industry: Gene Therapy
Technology: Cancer
Number Of Exists: Venture - Series Unknown
Estimated Revenue: $10M to $50M
Founded Date: 2006
Investors Number: 7